Evicenter
Wegovy (semaglutide) in Chronic weight management
Manufacturer
Novo Nordisk Inc.
Prescribing information
Wegovy (opens in a new tab)
Questions
61
Last updated

All questions

Specific populations: Wegovy (semaglutide) in chronic weight management

6 questions · 2 sources

Adolescents

How much weight do teenagers lose on Wegovy (STEP TEENS)?

Applies to Chronic weight management in pediatric patients aged 12 years and older with obesity (Wegovy injection)

How many teenagers on Wegovy reduce their BMI by at least 5%, 10%, or 15%?

Applies to Chronic weight management in pediatric patients aged 12 years and older with obesity (Wegovy injection)

Note: In the Table 18 rows, the first value is placebo and the second is WEGOVY 2.4 mg injection. Study 10 of the Prescribing Information has the same design and enrollment (68 weeks, 201 patients aged 12 years and older) as STEP TEENS on the Wegovy HCP site.

Can teenagers take Wegovy?

Applies to Chronic weight management in pediatric patients aged 12 years and older with obesity (Wegovy injection)

What is the Wegovy maintenance dose for teenagers?

Applies to Chronic weight management in pediatric patients aged 12 years and older with obesity (Wegovy injection)

What side effects do teenagers have on Wegovy?

Applies to Chronic weight management in pediatric patients aged 12 years and older with obesity (Wegovy injection)

Note: Table 5 columns are placebo (N=67) then WEGOVY 2.4 mg injection (N=133), in % of patients.

Specific populations

Can adults 65 and older take Wegovy?

Applies to Adults aged 65 and older receiving Wegovy for weight reduction

Note: The effectiveness statement and the fracture finding are from the CV outcomes trial in adults with established cardiovascular disease and either obesity or overweight.